Program
Timetable- Presidential Symposium
- ASH Special Lecture
- EHA Special Lecture
- Plenary Session
- Special Lecture
- Symposium
- JSH-ASH Joint Symposium
- JSH-EHA Joint Symposium
- Women Physicians Career Symposium
- JSH-EHA Travel Grant Awardee's Session in JSH2025
- Asian Joint Panel Discussion
As of September 30, 2025
Presidential Symposium
Therapeutic strategy for AML with FLT3 mutations
October 10（Fri.）10:50-11:50
- Chair：
- Hitoshi Kiyoi（Department of Hematology and Oncology,Nagoya University Graduate School of Medicine）
- Speaker：
- Mark James Levis（Johns Hopkins University）
Catherine Smith（UCSF）
ASH Special Lecture
Germ line CSF3R mutations in CNL
October 10（Fri.）11:50-12:20
- Chair：
- Koichi Akashi（Department of Medicine and Biosystemic Science）
- Speaker：
- Belinda Avalos（Atrium Health Levine Cancer）
EHA Special Lecture
Molecular monitoring of measurable residual disease (MRD) in acute myeloid leukemia (AML)
October 12（Sun.）11:10-11:40
- Chair：
- Hideo Harigae（Department of Hematology, Tohoku University Graduate School of Medicine）
- Speaker：
- Konstanze Döhner（University Hospital of Ulm）
Plenary Session
October 11（Sat.）12:40-14:10
- Chair：
- Seishi Ogawa（Kyoto University）
Toshihiro Miyamoto （Kanazawa University）
Special Lecture
Special Lecture 1
Molecular Genetics Guiding Treatment in Acute Myeloid Leukemia
October 11（Sat.）10:40-11:10
- Chair：
- Yasushi Miyazaki（Department of Hematology, Unit for Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University）
- Speaker：
- Hartmut Döhner（University Hospital of Ulm）
Special Lecture 2
Novel treatment strategies for chronic GVHD after allogeneic HCT
October 11（Sat.）14:10-14:40
- Chair：
- Kinuko Mitani（Dokkyo Medical University）
- Speaker：
- Stephanie J Lee（Clinical Research Division Fred Hutchinson Cancer Center）
Symposium
Symposium 1
Emerging treatment for B cell lymphoma
October 10（Fri.）8:30-10:30
- Chair：
- Koji Izutsu（National Cancer Center Hospital）
Lorenzo Falchi（Memorial Sloan-Kettering Cancer Center, New York, NY） - Speaker：
- Koji Kato（Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences）
Wei-Li Zhao（Shanghai Institute of Hematology）
Lorenzo Falchi（Memorial Sloan-Kettering Cancer Center, New York, NY）
Mark Roschewski（National Cancer Institute）
Symposium 2
Energy acquisition in hematopoietic stem cells
October 10（Fri.）8:30-10:30
- Chair：
- Ayako Nakamura-Ishizu（Tokyo Women's Medical University Department of Microanatomy and Developmental Biology）
Hideyo Hirai（Tokyo University of Pharmacy and Life Sciences） - Speaker：
- Ayako Nakamura-Ishizu（Tokyo Women's Medical University Department of Microanatomy and Developmental Biology）
Keiyo Takubo（Tohoku University Graduate School of Medicine / National Center for Global Health and Medicine）
Nina Cabezas-Wallscheid（Swiss Federal Institute of Technology (ETH Zürich), Zürich, Switzerland）
Yoshihiro Hayashi（Laboratory of Cancer Pathobiology and Therapeutics, College of Pharmaceutical Sciences, Ritsumeikan University）
Keisuke Ito（Albert Einstein College of Medicine）
Symposium 3
Exploring the Complement System in Hematology: Biological Insights and Emerging Therapeutic Prospects
October 10（Fri.）15:20-17:20
- Chair：
- Yasutaka Ueda（Department of Hematology and Oncology, Osaka University Graduate School of Medicine）
Naoshi Obara（University of Tsukuba） - Speaker：
- Norimitsu Inoue（Department of Molecular Genetics, Wakayama Medical University）
Dimitrios Mastellos（Director of Research Division of Biodiagnostic Sciences and Technologies, INRASTES, National Center for Scientific Research "Demokritos"）
Christoph Schmidt（University of Ulm Medical Center）
Toshiyuki Miyata（National Cerebral and Cardiovascular Center）
Symposium 4
Cutting edge of genetic basis and current immune therapies in multiple myeloma
October 11（Sat.）8:30-10:30
- Chair：
- Shinsuke Iida（Nagoya City University Institute of Medical and Pharmaceutical Sciences）
Yawara Kawano（Department of Hematology, Kumamoto University ） - Speaker：
- Mehmet Samur（Dana Farber Cancer Institute & Harvard TH Chan School of Public Health）
Yasunori Kogure（National Cancer Center Research Institute）
Krina K. Patel（The University of Texas MD Anderson Cancer Center）
Masaki Ri（Graduate School of Medical Sciences and Medical School, Nagoya City University）
Daisuke Minakata（Division of Hematology, Department of Medicine, Jichi Medical University）
Symposium 5
Development of novel therapies for myeloproliferative neoplasms
October 12（Sun.）8:30-10:30
- Chair：
- Yuka Sugimoto（Department of Hematology and Oncology, Mie University Graduate School of Medicine）
Tomoiku Takaku（Saitama Medical University） - Speaker：
- Naoto Takahashi（Akita University）
Hiroshi Ureshino（Saga University）
Kotaro Shide（Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki）
Prithviraj Bose（University of Texas MD Anderson Cancer Center）
Symposium 6
Risk of Thrombosis in unexpected places
October 12（Sun.）8:30-10:30
- Chair：
- Katsue Suzuki-Inoue（University of Yamanashi）
Keiji Nogami（Department of Pediatrics, Nara Medical University） - Speaker：
- Nan Wang（Columbia University Irving Medical Center）
Hanny Al-Samkari（The Peggy S. Blitz Endowed Chair in Hematology/Oncology, Massachusetts General Hospital / Associate Professor of Medicine, Harvard Medical School）
Azusa Nagao（Kansai Medical University Hospital）
Tomoko Narita（Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Science）
Symposium 7
Understanding germline findings in the era of genomic medicine
October 12（Sun.）8:30-10:30
- Chair：
- Emiko Sakaida（Department of Hematology, Chiba University Hospital）
Hideki Muramatsu（Department of Pediatrics, Nagoya University Graduate School of Medicine） - Speaker：
- Motohiro Kato（Department of Pediatrics, the University of Tokyo）
David Malkin（Division of Hematology/Oncology, The Hospital for Sick Children）
Satoshi Narumi（Department of Pediatrics, Keio University School of Medicine）
Hideki Makishima（Shinshu University）
Mizuki Watanabe（National Cancer Center Hospital, Japan）
Symposium 8
Importance of T cell fitness in cancer immunotherapy
October 12（Sun.）14:30-16:30
- Chair：
- Maiko Matsushita（Division of Clinical Physiology and Therapeutics, Keio University Faculty of Pharmacy）
Zinaida Good（Stanford University） - Speaker：
- Yuki Kagoya（Keio University School of Medicine）
Zinaida Good（Stanford University）
Seitaro Terakura（Nagoya University Graduate School of Medicine）
Mirco J Friedrich（Broad Institute of MIT and Harvard）
JSH-ASH Joint Symposium
Recent advances in molecular pathogenesis of acute leukemia
October 10（Fri.）15:20-17:20
- Chair：
- Takahiro Yamauchi（Department of Hematology and Oncology, University of Fukui）
Belinda Avalos（Atrium Health Levine Cancer） - Speaker：
- Emily B. Heikamp（Dana-Farber Cancer Institute/Harvard Medical School）
Robert K. Bradley（Fred Hutchinson Cancer Center）
Akinori Yoda（Kyoto University）
Ayana Kon（Division of Hematology and Tumor Biology, The Institute of Medical Science,The University of Tokyo）
JSH-EHA Joint Symposium
Development of Novel Therapies to Prevent Post-Transplant Recurrence
October 11（Sat.）14:50-16:50
- Chair：
- Naoyuki Uchida（Toranomon Hospital）
Konstanze Döhner（University Hospital of Ulm） - Speaker：
- Luca Vago（San Raffaele Scientific Institute）
Hiroshi Kawamoto（Institute for Life and Medical Sciences, Kyoto University）
Hirohisa Nakamae（Department of Hematology, Osaka Metropolitan University Graduate School of Medicine）
Yuho Najima（Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital）
Women Physicians Career Symposium
October 11（Sat.）8:30-10:30
- Chair：
- Junko Takita（Department of Pediatrics, Kyoto University）
Motoko Yamaguchi（Mie University Graduate School of Medicine） - Speaker：
- Stephanie J Lee（Clinical Research Division Fred Hutchinson Cancer Center）
- Mentor：
- Yoshiko Atsuta（Japanese Data Center for Hematopoietic Cell Transplantation）
- Mentee：
- Marie Ohbiki（The Japanese Data Center for Hematopoietic Cell Transplantation）
- Panelist：
- Emiko Sakaida（Department of Hematology, Chiba University Hospital）
Yuki Asano-mori（Toranomon Hospital）
JSH-EHA Travel Grant Awardee's Session in JSH2025
October 11（Sat.）8:30-10:30
- Chair：
- Seishi Ogawa（Department of Pathology and Tumor Biology, Kyoto University）
Naoki Hosen（Osaka University）
iPSC-derived CD2-targeted chimeric antigen receptor-T cell therapy for T cell malignancies
Shintaro Kinoshita（Department of Hematology, Juntendo University School of Medicine, Japan）
Chronic exposure to CAR-T secretome depletes human HSCs via TNF-α/IFN-γ-BATF2 signaling axis, reversible by cAMP pathway activation
Siva Sai Naga Anurag Muddineni（Tel Aviv University, Israel）
Immune-driven selection and frequent detection of PNH clones in post-CAR-T therapy hematopoietic failure
Yuki Nukii（Hematol., Kanazawa Univ., Ishikawa, Japan）
Outcomes of allogeneic transplantation for secondary myelodysplastic syndrome evolved from aplastic anemia and paroxysmal nocturnal hemoglobinuria
Machiko Fujioka（Department of Hematology, Sasebo City General Hospital, Sasebo, Japan / Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan）
The CDIN1-Codanin-1 complex, defective in congenital dyserythropoietic anaemia type I, is an RNA nuclease
Sanja Brolih（Center of Medicines Discovery, University of Oxford, United Kingdom）
SLF2, a novel causative gene for inherited bone marrow failure syndromes and MDS, and its significance in hematopoietic stem cell aging and leukemic progression
Sho Shibata（Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan / Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan）
Management of patients with hematological disorders with germline predispositions in Japan
Mizuki Watanabe（Hematology, Kyoto University Hospital, Kyoto, Japan / Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan / Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan）
Genome-wide CRISPR screening identifies CRL1 as a therapeutic target for restoring CD19 expression and improving immunotherapy efficacy in B-cell malignancies
Narendra Varma Gottumukkala（Central European Institute of Technology (CEITEC)-Masaryk University, Czechia）
Integrated genome and epigenome profiling of pediatric leukemia using nanopore-based targeted adaptive sampling long-read sequencing
Shota Kato（Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan）
Whole-genome sequencing of 431 patients reveals the coding and non-coding mutation landscapes of pediatric acute myeloid leukemia
Kaito Mimura（Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan）
A novel STAT5B-driven mouse model of hepatosplenic T cell lymphoma reveals therapeutic efficacy of JAK inhibitors
Myint Myat Khine Aung（Institute for Medical Biochemistry, University of Veterinary Medicine, Austria）
Stromal cell diversity in angioimmunoblastic T-cell lymphoma through spatial transcriptome analysis at single cell resolution
Yuki Shimizu（Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan）
Modern prognostication in IgM and lymphoplasmacytic lymphoma associated systemic AL amyloidosis: analysis from the United Kingdom
Jahanzaib Khwaja（National Amyloidosis Centre, United Kingdom）
（No presentation）The spatial dysregulation of microenvironment involving Tenascin-C expressing cell can be a clinically applicable marker for fibrosis progression in the patients with myeloproliferative neoplasms
Keiki Nagaharu（Hematology and Oncology, Mie University, Tsu, Japan /Lund University, Laboratory Medicine, Lund, Sweden）
（No presentation）Degradation of IKZF1 via E3 ubiquitin ligase X by DNA demethylating agents is a potential therapeutic target for multiple myeloma
Yuta Yamamoto（Division of Hematology, Saga University, Japan / Department of Drug Discovery and Biomedical Sciences, Saga University, Japan）
Asian Joint Panel Discussion
Novel therapeutic approaches for refractory hematological malignancies
October 11（Sat.）14:50-16:50
- Chair：
- Ritsuro Suzuki（Shimane University）
Kim Seok-Jin（Sungkyunkwan University School of Medicine, Samsung Medical Center） - Speaker：
- Ayumi Fujimoto（Pathology Project for Molecular Targets, Cancer Institute）
Kannadit Prayongratana（Phramongkutklao Hospital）
Avinash Kumar Singh（Paras HMRI Hospital）
Youngil Koh（Seoul National University）
Xiaowen Tang（The First Affiliated Hospital of Soochow University）
Than Hein（National Cancer Centre Singapore, Singapore General Hospital）
Jia-Hau Liu（National Taiwan University Cancer Center）